Pacific Biosciences of California (PACB) — Capital Reinvestment Ratio
Latest as of March 2020:
0.00x
Pacific Biosciences of California (PACB) has a Capital Reinvestment Ratio of 0.00x as of March 2020, meaning it reinvests 0% of its operating cash flow ($75.36 Million) in capital expenditures ($117.00K). See PACB FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$75.36 Million
USD
Capital Expenditures
$117.00K
USD
Data as of
Mar 2020
Most recent filing
Pacific Biosciences of California Capital Reinvestment Ratio (2020–2020)
This chart tracks Pacific Biosciences of California's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Pacific Biosciences of California (2020–2020)
Year-by-year Capital Reinvestment Ratio for Pacific Biosciences of California from 2020 to 2020. For live market cap and broader valuation context, see Pacific Biosciences of California stock valuation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.05x | $19.50 Million | $1.04 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow